haloperidol has been researched along with Brain Disorders in 39 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The encephalopathy was worsened by hyperthermia, dehydration, and reintroduction of haloperidol, 5 days after the first discontinuation of the neuroleptic." | 5.30 | [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]. ( de Barsy, T; Delbecq, J; Depré, A; Ghariani, S; Gille, M; Piéret, F; Saussu, F, 1997) |
| "We summarise preliminary findings from our ongoing magnetic resonance imaging and spectroscopy studies of first-episode schizophrenia patients being conducted prospectively from index evaluations through a period of two years; during this period, patients were treated with either a conventional antipsychotic such as haloperidol, or the atypical risperidone." | 3.70 | Research and treatment strategies in first-episode psychoses. The Pittsburgh experience. ( Haas, GL; Keshavan, MS; Pettegrew, JW; Schooler, NR; Sweeney, JA, 1998) |
| "Choreoathetotic syndromes are frequently observed in children after congenital cardiopathy surgery." | 1.36 | Late-onset choreoathetotic syndrome following heart surgery. ( Alessandrini, F; Avesani, M; Bertolasi, L; Bovi, P; Buffone, CE; Moretto, G; Musso, A; Ottaviani, S; Passarin, MG; Petrilli, G; Romito, S; Santini, F, 2010) |
| " Chronic administration of haloperidol (1 mg/kg, i." | 1.35 | Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2008) |
| "To describe a case of possible toxic encephalopathy in a surgical patient receiving high-dose intravenous haloperidol." | 1.30 | Possible toxic encephalopathy following high-dose intravenous haloperidol. ( Maxa, JL; Ogu, CC; Taleghani, AM; Tanzi, M, 1997) |
| "The encephalopathy was worsened by hyperthermia, dehydration, and reintroduction of haloperidol, 5 days after the first discontinuation of the neuroleptic." | 1.30 | [Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning]. ( de Barsy, T; Delbecq, J; Depré, A; Ghariani, S; Gille, M; Piéret, F; Saussu, F, 1997) |
| "Cysticercosis is a parasitic disease endemic in several developing countries where people consume raw or insufficiently cooked pork." | 1.28 | You drive me crazy: a case report of acute psychosis and neurocysticercosis. ( Milette, PC; Shriqui, CL, 1992) |
| " Evidence for this is based on the fact that in our patients and others mentioned in the literature the dosage and blood levels of lithium were not high." | 1.27 | Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases. ( Hurwitz, MD; Sandyk, R, 1983) |
| " A long-term use of haloperidol did not exert any significant influence on the cortical function of the formation of conditioned reflexes, but there was a retardation in the fixation of new conditioned reflexes after 6 months of drug administration." | 1.26 | [Pathophysiologic and morphologic changes in the central nervous system following long-term haloperidol administration]. ( Bobritskaia, ZM; Gorbatko, LG; Gordienko, ZhP; Litvinova, NM, 1981) |
| "Agitated patients with organic brain disorders represent relatively common diagnostic and management problems." | 1.26 | Treatment of the agitated patient with an organic brain disorder. ( Fauman, MA, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (53.85) | 18.7374 |
| 1990's | 13 (33.33) | 18.2507 |
| 2000's | 4 (10.26) | 29.6817 |
| 2010's | 1 (2.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passarin, MG | 1 |
| Romito, S | 1 |
| Avesani, M | 1 |
| Alessandrini, F | 1 |
| Petrilli, G | 1 |
| Santini, F | 1 |
| Bertolasi, L | 1 |
| Musso, A | 1 |
| Buffone, CE | 1 |
| Ottaviani, S | 1 |
| Bovi, P | 1 |
| Moretto, G | 1 |
| Laplante, F | 1 |
| Stevenson, CW | 1 |
| Gratton, A | 1 |
| Srivastava, LK | 1 |
| Quirion, R | 1 |
| Wehrschuetz, M | 1 |
| Simbrunner, J | 1 |
| Enzinger, C | 1 |
| Ebner, F | 1 |
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Barbosa, ER | 1 |
| Marchiori, PE | 1 |
| Scaff, M | 1 |
| de Assis, JL | 1 |
| Sandyk, R | 1 |
| Hurwitz, MD | 1 |
| Fage, D | 1 |
| Guerin, B | 1 |
| Feuerstein, C | 1 |
| Demenge, P | 1 |
| Scatton, B | 1 |
| Appelbaum, PS | 1 |
| Roth, LH | 1 |
| Sumners, C | 1 |
| Woodruff, GN | 1 |
| Poat, JA | 1 |
| Litvinova, NM | 1 |
| Bobritskaia, ZM | 1 |
| Gordienko, ZhP | 1 |
| Gorbatko, LG | 1 |
| Ouagazzal, A | 1 |
| Nieoullon, A | 1 |
| Amalric, M | 1 |
| Bureau, YR | 1 |
| Persinger, MA | 1 |
| Goldman, SA | 2 |
| Maxa, JL | 1 |
| Taleghani, AM | 1 |
| Ogu, CC | 1 |
| Tanzi, M | 1 |
| Gille, M | 1 |
| Ghariani, S | 1 |
| Piéret, F | 1 |
| Delbecq, J | 1 |
| Depré, A | 1 |
| Saussu, F | 1 |
| de Barsy, T | 1 |
| Roe, DL | 1 |
| Bardgett, ME | 1 |
| Csernansky, CA | 1 |
| Csernansky, JG | 1 |
| Breggin, PR | 1 |
| Keshavan, MS | 1 |
| Schooler, NR | 1 |
| Sweeney, JA | 1 |
| Haas, GL | 1 |
| Pettegrew, JW | 1 |
| Joseph, MH | 1 |
| Peters, SL | 1 |
| Moran, PM | 1 |
| Grigoryan, GA | 1 |
| Young, AM | 1 |
| Gray, JA | 1 |
| Fauman, MA | 1 |
| Veits, HR | 1 |
| Destee, A | 1 |
| Lehembre, P | 1 |
| Petit, H | 1 |
| Warot, P | 1 |
| Shriqui, CL | 1 |
| Milette, PC | 1 |
| Pontecorvo, MJ | 1 |
| Karbon, EW | 1 |
| Goode, S | 1 |
| Clissold, DB | 1 |
| Borosky, SA | 1 |
| Patch, RJ | 1 |
| Ferkany, JW | 1 |
| Johansson, P | 1 |
| Jurand, A | 1 |
| Martin, LV | 1 |
| Weihmuller, FB | 1 |
| Hadjiconstantinou, M | 1 |
| Bruno, JP | 1 |
| Neff, NH | 1 |
| Niss, AI | 1 |
| Trubkovich, MIa | 1 |
| Nisenbaum, ES | 1 |
| Stricker, EM | 1 |
| Zigmond, MJ | 1 |
| Berger, TW | 1 |
| Nikulina, IuA | 1 |
| Skrinskaia, IuA | 1 |
| Popova, NK | 1 |
| Browne, JL | 1 |
| Hart, RR | 1 |
| Pellis, SM | 1 |
| Chen, YC | 1 |
| Chesire, RM | 1 |
| Teitelbaum, P | 1 |
| Wahnschaffe, U | 1 |
| Esslen, J | 1 |
| Walsh, AC | 1 |
| Walsh, BH | 1 |
| O'Neill, DP | 1 |
| Klawans, HL | 1 |
| Holmes, AW | 1 |
| Cohen, WJ | 1 |
| Cohen, NH | 1 |
| Matveev, VF | 1 |
| Lapides, MI | 1 |
| Mamtseva, VN | 1 |
2 reviews available for haloperidol and Brain Disorders
| Article | Year |
|---|---|
Lithium and neuroleptics in combination: is there enhancement of neurotoxicity leading to permanent sequelae?
Topics: Adult; Analysis of Variance; Antimanic Agents; Antipsychotic Agents; Brain; Brain Diseases; Drug Int | 1996 |
Organic delusional disorder on a consultation-liaison psychiatry service. Report and review.
Topics: Adult; Age Factors; Aged; Brain Diseases; Delusions; Diagnosis, Differential; Electroencephalography | 1992 |
37 other studies available for haloperidol and Brain Disorders
| Article | Year |
|---|---|
Late-onset choreoathetotic syndrome following heart surgery.
Topics: Age of Onset; Anti-Dyskinesia Agents; Basal Ganglia; Brain Diseases; Cardiac Surgical Procedures; Ch | 2010 |
Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
Topics: Acetylcholine; Animals; Animals, Newborn; Benzazepines; Brain Diseases; Dopamine; Dopamine Antagonis | 2004 |
[Hemiballism-hemichorea syndrome].
Topics: Anti-Dyskinesia Agents; Brain Diseases; Cerebrovascular Circulation; Chorea; Drug Therapy, Combinati | 2007 |
Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Topics: Animals; Antipsychotic Agents; Brain Diseases; Control Groups; Disease Models, Animal; Dopamine; Dys | 2008 |
[Huntington chorea: report of 16 cases].
Topics: Adult; Aged; Brain Diseases; Chlorpromazine; Dementia; Diagnosis, Differential; Female; gamma-Aminob | 1983 |
Toxic irreversible encephalopathy induced by lithium carbonate and haloperidol. A report of 2 cases.
Topics: Adult; Bipolar Disorder; Brain Diseases; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female | 1983 |
Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
Topics: Acetylcholine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Ergolines; Haloperidol; Male; Per | 1984 |
Involuntary treatment in medicine and psychiatry.
Topics: Aged; Brain Diseases; Female; Haloperidol; Hospitals, General; Hospitals, Psychiatric; Humans; Infus | 1984 |
Effects of specific dopamine lesions and dopamine receptor sensitivity on angiotensin II- and carbachol-induced thirst in rats.
Topics: Angiotensin II; Animals; Brain Diseases; Carbachol; Corpus Striatum; Dopamine; Haloperidol; Hydroxyd | 1981 |
[Pathophysiologic and morphologic changes in the central nervous system following long-term haloperidol administration].
Topics: Animals; Basal Ganglia Diseases; Brain Diseases; Caudate Nucleus; Cerebral Cortex; Conditioning, Cla | 1981 |
Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
Topics: Amphetamine; Animals; Brain; Brain Diseases; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamin | 1994 |
Transient blocking of persistent gnawing by haloperidol in rats with seizure-induced multifocal brain damage.
Topics: Animals; Behavior, Animal; Brain Diseases; Female; Haloperidol; Limbic System; Mastication; Rats; Ra | 1993 |
Possible toxic encephalopathy following high-dose intravenous haloperidol.
Topics: Antipsychotic Agents; Anxiety; Brain Diseases; Haloperidol; Humans; Male; Middle Aged | 1997 |
[Acute encephalomyopathy and persistent cerebellar syndrome after lithium salt and haloperidol poisoning].
Topics: Acute Disease; Adult; Antidepressive Agents; Antipsychotic Agents; Brain Diseases; Cerebellar Diseas | 1997 |
Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.
Topics: Animals; Antipsychotic Agents; Brain; Brain Diseases; Cell Count; Clozapine; Dose-Response Relations | 1998 |
Does clozapine treatment cause brain disease?
Topics: Adult; Age Factors; Brain Diseases; Child; Clozapine; Drug Therapy, Combination; Haloperidol; Humans | 1998 |
Research and treatment strategies in first-episode psychoses. The Pittsburgh experience.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain Diseases; Developmental Disabilities; Episode of Care | 1998 |
Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning.
Topics: Amphetamine; Animals; Association Learning; Behavior, Animal; Brain Diseases; Conditioning, Psycholo | 2000 |
Treatment of the agitated patient with an organic brain disorder.
Topics: Adult; Aged; Antipsychotic Agents; Brain Damage, Chronic; Brain Diseases; Brain Injuries; Haloperido | 1978 |
Haloperidol encephalopathy: case report.
Topics: Adult; Brain Diseases; Haloperidol; Humans; Male; Military Medicine | 1978 |
[Toxic encephalopathy caused by the combination of lithium and haloperidol].
Topics: Adjustment Disorders; Brain Diseases; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Male; | 1978 |
You drive me crazy: a case report of acute psychosis and neurocysticercosis.
Topics: Acute Disease; Adult; Brain Diseases; Cysticercosis; Dexamethasone; Electroencephalography; Female; | 1992 |
Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents.
Topics: Animals; Anticonvulsants; Brain Diseases; Electroshock; Haloperidol; Hypoxia; Male; Mice; Mice, Inbr | 1991 |
Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.
Topics: Animals; Azo Compounds; Behavior, Animal; Brain Diseases; Corpus Striatum; Dyskinesia, Drug-Induced; | 1990 |
Teratogenic potential of two neurotropic drugs, haloperidol and dextromoramide, tested on mouse embryos.
Topics: Animals; Brain Diseases; Dextromoramide; Dose-Response Relationship, Drug; Female; Haloperidol; Leth | 1990 |
Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice.
Topics: Animals; Brain Diseases; Catalepsy; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; G(M1) Gangl | 1989 |
[Various rarely encountered adverse effects and complications of psychopharmacotherapy].
Topics: Adult; Agnosia; Amitriptyline; Apraxias; Brain Diseases; Cerebral Cortex; Haloperidol; Humans; Male; | 1985 |
Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery.
Topics: Action Potentials; Animals; Brain Diseases; Corpus Striatum; Dopamine; Haloperidol; Hydroxydopamines | 1986 |
[Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Brai | 1988 |
Exacerbation of tardive dyskinesia by Joseph disease.
Topics: Aged; Brain Diseases; Cerebellar Ataxia; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Ment | 1986 |
Head displacement and bracing in haloperidol-treated rats compared to rats with lateral hypothalamic damage.
Topics: Animals; Brain Diseases; Catalepsy; Disease Models, Animal; Haloperidol; Hydroxydopamines; Hypothala | 1985 |
Structural evidence for the neurotoxicity of methylamphetamine in the frontal cortex of gerbils (Meriones unguiculatus): a light and electron microscopical study.
Topics: Animals; Brain Diseases; Dopamine; Drug Interactions; Female; Frontal Lobe; Gerbillinae; Haloperidol | 1985 |
Presenile dementia: further experience with an anticoagulant-psychotherapy regimen.
Topics: Adult; Aged; Anticoagulants; Anxiety; Atrophy; Brain Diseases; Dementia; Dicumarol; Fear; Female; Ha | 1974 |
Treatment of choreoathetotic movements in chronic liver disease with a dopamine-blocking agent. Pathophysiologic implications.
Topics: Aged; Basal Ganglia; Brain Diseases; Chorea; Dopamine; Electrocardiography; Electroencephalography; | 1971 |
Lithium carbonate, haloperidol, and irreversible brain damage.
Topics: Acute Disease; Adult; Bipolar Disorder; Brain; Brain Diseases; Carbonates; Chronic Disease; Consciou | 1974 |
[Pathomorphologic changes in the brain during long-term combined administration of lysergamide (LSD-25) and haloperidol (experimental morphologic study) s].
Topics: Animals; Brain Diseases; Cerebral Cortex; DNA; Haloperidol; Histocytochemistry; Hypothalamus; Lyserg | 1971 |
[On the treatment of psycopath-like states in children with psychotropic drugs after infectious and traumatic disorders of the central nervous system].
Topics: Adolescent; Antidepressive Agents; Antisocial Personality Disorder; Brain Diseases; Brain Injuries; | 1967 |